283 related articles for article (PubMed ID: 20648630)
1. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Habibi D; Jalili RB; Forouzandeh F; Ong CJ; Ghahary A
J Cell Physiol; 2010 Oct; 225(1):196-205. PubMed ID: 20648630
[TBL] [Abstract][Full Text] [Related]
2. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
3. Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.
Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
Wound Repair Regen; 2008; 16(3):379-87. PubMed ID: 18471256
[TBL] [Abstract][Full Text] [Related]
4. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Uludag H; Kilani RT; Karami A; Li Y; Iwashina T; Ghahary A
J Cell Physiol; 2004 Oct; 201(1):146-54. PubMed ID: 15281097
[TBL] [Abstract][Full Text] [Related]
5. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
8. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor.
Ryu YH; Kim JC
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4148-52. PubMed ID: 17724200
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.
Brenk M; Scheler M; Koch S; Neumann J; Takikawa O; Häcker G; Bieber T; von Bubnoff D
J Immunol; 2009 Jul; 183(1):145-54. PubMed ID: 19535644
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Immunology; 2015 Oct; 146(2):292-300. PubMed ID: 26147366
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells.
Cheng CW; Shieh PC; Lin YC; Chen YJ; Lin YH; Kuo DH; Liu JY; Kao JY; Kao MC; Way TD
J Agric Food Chem; 2010 Jan; 58(2):887-94. PubMed ID: 19928918
[TBL] [Abstract][Full Text] [Related]
13. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H
Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674
[TBL] [Abstract][Full Text] [Related]
15. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor.
Ghahary A; Li Y; Tredget EE; Kilani RT; Iwashina T; Karami A; Lin X
J Invest Dermatol; 2004 Apr; 122(4):953-64. PubMed ID: 15102086
[TBL] [Abstract][Full Text] [Related]
16. Amino acid deprivation links BLIMP-1 to the immunomodulatory enzyme indoleamine 2,3-dioxygenase.
Barnes NA; Stephenson SJ; Tooze RM; Doody GM
J Immunol; 2009 Nov; 183(9):5768-77. PubMed ID: 19828629
[TBL] [Abstract][Full Text] [Related]
17. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage.
Serbecic N; Beutelspacher SC
Exp Eye Res; 2006 Mar; 82(3):416-26. PubMed ID: 16318852
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice.
Liu L; Liu H; Mah C; Fletcher BS
Gene Ther; 2009 Jun; 16(6):724-33. PubMed ID: 19262614
[TBL] [Abstract][Full Text] [Related]
20. Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts.
Jalili RB; Rayat GR; Rajotte RV; Ghahary A
J Cell Physiol; 2007 Oct; 213(1):137-43. PubMed ID: 17477384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
